[Cervical cancer in the young woman].
Uterine cervix carcinoma is considered by some authors to carry a poor prognosis in young patients (< 35 years of age). From 10 years, many series have been published with divergent conclusions. However, a group of patients with poor prognosis could be individualized; age < 30 years, locally aggressive tumour, poorly differentiated, nodal involvement, amplification of c-Myc proto-oncogene. New imaging technics and coelioscopy could help to the diagnosis. The role of combined treatment remains to be demonstrated and biological factors (kinetics, oxygenation) will help in the future to more adapted treatments.
Gerbaulet
A
A
Curiethérapie et radiothérapie gynécologique, Institut Gustave-Roussy, Villejuif, France.
Lartigau
E
E
Haie-Meder
C
C
Michel
G
G
Prade
M
M
Lhomme
C
C
D000328:Adult; D000367:Age Factors; D001918:Brachytherapy; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007044:Hysterectomy; D009367:Neoplasm Staging; D011379:Prognosis; D000090063:Proto-Oncogene Mas; D012307:Risk Factors; D015996:Survival Rate; D016896:Treatment Outcome; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy
Le cancer du col utérin de la femme jeune.